Takuji Mori
- Oncology top 5%
- Chemokine receptors and signaling 4
- Cancer Research top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment 4
-
- Epigenetics and DNA Methylation 5
- Genomics and Chromatin Dynamics 3
-
- Gastric Cancer Management and Outcomes 6
- Metastasis and carcinoma case studies 2
-
- Intraperitoneal and Appendiceal Malignancies 2
- Co-authors
- Dave S.�B. HoonKazuo KoyanagiNaoyuki UmetaniJoseph KimSteve R. MartinezSteven O’DayChristine KuoHe-Jing Wang
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- JapanUnited StatesIndia
In The Last Decade
Takuji Mori
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 79
- Oncology 515
- Cancer Research 254
- Immunology 245
- Gastroenterology 60
- Molecular Biology 513
Countries citing papers authored by Takuji Mori
This map shows the geographic impact of Takuji Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuji Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuji Mori more than expected).
Fields of papers citing papers by Takuji Mori
This network shows the impact of papers produced by Takuji Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuji Mori. The network helps show where Takuji Mori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takuji Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2016 | 4 | |
| 3 | 2014 | 18 | |
| 4 | 2011 | 0 | |
| 5 | 2007 | 15 | |
| 6 | CXCL12 and CCL21 chemokine expression in inflammatory draining lymph nodes promote melanoma metastasis | 2006 | 1 |
| 7 | 2006 | 57 | |
| 8 | 2006 | 5 | |
| 9 | 2006 | 147 | |
| 10 | 2006 | 76 | |
| 11 | 2005 | 35 | |
| 12 | 2005 | 91 | |
| 13 | 2005 | 104 | |
| 14 | 2005 | 82 | |
| 15 | 2004 | 27 | |
| 16 | 2003 | 26 | |
| 17 | 2003 | 19 | |
| 18 | 2003 | 32 | |
| 19 | 1989 | 2 | |
| 20 | 1988 | 1 |
About Takuji Mori
Takuji Mori is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Gastric Cancer Management and Outcomes (6 papers), Epigenetics and DNA Methylation (5 papers), Chemokine receptors and signaling (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Genomics and Chromatin Dynamics (3 papers), Metastasis and carcinoma case studies (2 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). The work is most often cited by research in Oncology (515 citations), Cancer Research (254 citations) and Immunology (245 citations). Takuji Mori has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Dave S.�B. Hoon, Kazuo Koyanagi, Naoyuki Umetani, Joseph Kim, Steve R. Martinez, Steven O’Day, Christine Kuo, He-Jing Wang, Hiroya Takeuchi and Donald L. Morton. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.